Chugai Pharmaceutical Co. Ltd. (CHGCY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chugai Pharmaceutical Co....

    OTC: CHGCY · Real-Time Price · USD
    22.30
    0.11 (0.50%)
    At close: Sep 05, 2025, 3:55 PM
    22.26
    -0.19%
    After-hours: Sep 05, 2025, 03:47 PM EDT

    Chugai Pharmaceutical Income Statement

    Financials in JPY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1,170.6B 1,111.4B 1,259.9B 999.76B
    Cost of Revenue
    		 339.41B 413.31B 476.25B 338.15B
    Gross Profit
    		 831.2B 698.06B 783.7B 661.61B
    Operating Income
    		 542B 439.17B 533.31B 421.9B
    Interest Income
    		 5M 4.65B 182M 166M
    Pretax Income
    		 543.03B 443.82B 531.17B 419.38B
    Net Income
    		 387.32B 325.47B 374.43B 303B
    Selling & General & Admin
    		 110.1B 112.58B 100.76B 102.42B
    Research & Development
    		 181.44B 174.87B 149.63B 137.3B
    Other Expenses
    		 -2.34B -28.56B -2.13B n/a
    Operating Expenses
    		 289.2B 258.89B 250.39B 239.72B
    Interest Expense
    		 -1.03B n/a 61M 48M
    Selling & Marketing Expenses
    		 110.1B 112.58B 77.15B 76.59B
    Cost & Expenses
    		 628.61B 672.19B 726.64B 577.86B
    Income Tax Expense
    		 155.72B 118.35B 156.74B 116.39B
    Shares Outstanding (Basic)
    		 3.29B 3.29B 3.29B 6.58B
    Shares Outstanding (Diluted)
    		 3.29B 3.29B 3.29B 6.58B
    EPS (Basic)
    		 117.70 98.90 113.82 46.06
    EPS (Diluted)
    		 117.68 98.90 113.79 46.04
    EBITDA
    		 542B 443.85B 531.23B 419.43B
    EBIT
    		 542B 443.85B 531.23B 419.43B
    Depreciation & Amortization
    		 n/a 4.67B 31.43B 30.87B

    Add to Watchlist